Treatment Goals
Diagnostic testing
Risk Factors and Risk Estimation
Treatments
New Guideline Grabbag
100

Achieving LDL-C of this level or lower is recommended for patients with a history of ASCVD at very high risk

what is <55 md/dL?


100

This highly atherogenic LDL-like particle should now be tested once in every adult 

what is lipoprotein(a)?

100

This risk calculator has replaced the pooled cohort equations and can estimate ASCVD risk starting at age 30

what is PREVENT?

100

When >50% LDL-C lowering is needed to achieve your target, start with atorvastatin 40-80 mg, or rosuvastatin at one of these two doses.

What is 20 or 40 mg?

100

Triglyceride levels >500 should in nearly all cases warrant a referral to what resource?

What is a nutritionist?

200

This biomarker can be used to target residual risk once LDL-C goals are met, especially in patients with diabetes and high triglycerides

what is Apolipoprotein B?

200

The interval for lipid re-testing recommended for patients already on LDL lowering therapy

What is 6-12 months?


200

This level of 10-year risk is now considered high risk in primary prevention patients, warranting an LDL-C goal of <70 mg/dL

what is >10%?

200

This oral LDL lowering medication is still considered second line after statins, but is now recommended in primary prevention populations

What is ezetimibe?

200

The new approach to risk estimation is known as "C-P-R", which stands for "Calculate-this-Reclassify"

What is Personalize?

300

General LDL-C treatment goal for patients on statins for primary prevention, if no additional high risk conditions are present

What is <100 mg/dL?  (AND 30-49% reduction)

300

These two comorbidities have been added to diabetes as an automatic indication for statin therapy in adults >40

What are CKD (stage 3+) and HIV?

300

PCOS has been added to early menopause, defined as occurring prior to this age, as an important risk enhancing factor to consider in determining ASCVD risk

What is <45 years old?

Other reproductive risk markers for women:

- Pre-eclampsia 

- Preterm birth (<37 weeks) 

- Early menarche (<10 years)

- Recurrent pregnancy loss

- Gestational diabetes 

- Gestational hypertension

300

This siRNA-based PCSK9 inhibitor is recommended by the guidelines as an option that may improve medication adherence

what is inclisiran?

300

This syndrome which was defined by the AHA in 2023 and emphasizes the linkage between CVD, CKD, DM2 and obesity, is listed as a major risk factor for LDL-C/ApoB discordance

What is CKM syndrome? (Cardiovascular-Kidney-Metabolic syndrome)

400

Non-HDL-C goal for anyone with an LDL-C goal of <70 mg/dL

what is <100 mg/dL?

400

The Martin/Hopkins equation or Sampson (NIH) equation should replace the old Friedwald equation, which was previously used to estimate this metric on a lipid panel

What is LDL-C?

400
This modifiable risk factor, if present, should limit the reassurance provided by CAC 0

What is smoking?

Other, non-modifiable RFs:

  • Familial hypercholesterolemia

  • LDL ≥190

  • Diabetes

  • Strong family history of premature ASCVD

400

This inhibitor of cholesterol synthesis which works upstream of statins is now recommended for statin intolerant patients after considering ezetimibe and PSCK9 inhibitors

what is bempedoic acid?

400

In patients with elevations in both LDL-C and Lp(a), if LDL-C goals are not met on max-dose statin therapy, this class of medications should be used as second line

what are PSCK9 inhibitors?

500

LDL-C treatment goal for all patients with FH but without clinical ASCVD

what is <70 mg/dL? (previously <100 mg /dL)

500

Even in patients without a history of clinical ASCVD, a CAC score exceeding this number should warrant an LDL-C goal of <55 mg/dL

what is 1000 Agaston units?

500

CAC score >100, or over what percentile, is cited as a threshold warranting an LDL-C goal of under 70 mg/dL

what is >75th %ile?

500

Rosuvastatin, pravastatin, or this other muscle-friendly statin studied in the REPRIEVE trial, are preferred in people living with HIV due to fewer drug interactions.

What is pitavastatin?

500

Optimal early control of modifiable cardiovascular risk factors is recommended to reduce ASCVD risk in patients with Lp(a) levels above what threshold?

what is >125 nmol/L (or >50 mg/dL)?